The number of people with susceptibility test result for rifampicin in Singapore
Singapore: The number of people with susceptibility test result for rifampicin was 1,051 in 2021. ▼ Falling
Latest (2021)
1,051
Change on year
down 1.4%
World rank
65th
of 155 countries
All-time high
1,122
in 2018
All-time low
1,032
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Singapore, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Singapore recorded 1,051 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of down 1.4% on the previous year and down 5.9% over five years.
That places Singapore 65th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,117 | — |
| 2018 | 1,122 | +0.4% |
| 2019 | 1,032 | -8.0% |
| 2020 | 1,066 | +3.3% |
| 2021 | 1,051 | -1.4% |
Singapore compared with similar countries
- Singapore's 1,051 is above the median for high income countries, which is 142, 7.4× the median. (61 countries reporting)
- Singapore's 1,051 is above the median for East Asia & Pacific, which is 185, 5.7× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,090 | 1,032 | 1,122 | 3 |
| 2020s | 1,058 | 1,051 | 1,066 | 2 |
Countries ranked near Singapore
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.93 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0196 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Singapore?
- The number of people with susceptibility test result for rifampicin in Singapore was 1,051 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Singapore?
- The highest recorded value was 1,122 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Singapore?
- The lowest recorded value was 1,032 in 2019.
- How does Singapore rank for the number of people with susceptibility test result for rifampicin?
- Singapore ranks 65th out of 155 countries with data for 2021.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).